Skip to main content
. 2021 Mar 5;10(5):1088. doi: 10.3390/jcm10051088

Table 2.

Studies that investigated erectile dysfunction (ED) and reduced libido prevalence in HIV patients.

Study n Age MSM (%) IV Drug Use (%) Reduced SD (%) ED (%) ED Diagnostic Tool
Lallemand et al. (2002) [89] 156 40.5 ± 7.7 * 100 NR 89 86 IIEF-15
Ende et al. (2006) [87] 118 41 (28–67) § 70 7 NA 74 IIEF-5
Asboe et al. (2007) [69] 668 - 73 - 24 33 IIEF-15
Crum-Cianflone et al. (2007) [90] 285 39 (19–72) * NR 8 NR 61.4 IIEF-15
Guaraldi et al. (2007) [88] 357 45 (45–46) * 43 NR NR 53.2 IIEF-15
Moreno-Pérez et al. (2010) [91] 90 42 ± 8.2 * 80 0 NR 53.4 IIEF-15
Rochira et al. (2011) [79] 247 45 (20–69) § NR NR 65.2 53.4 IIEF-15
Guaraldi et al. (2012) [45] 133 49 * 52 26 NR 59.3 IIEF-15
Zona et al. (2012) ¶ [11] 444 44.8 ± 5.9 * 43 34 NR 54.5 IIEF-15
Hart et al. (2012) ¶ [92] 1340 48 (42–54) § 100 NR NR 21 IIEF-MSM
Vansintejan et al. (2013) [93] 72 41 ± 10 * 100 NR 15 56 IIEF-5 **
Wang et al. (2013) [95] 4064 46 § NR NR NR 24 IIIEF-15 ‡‡
Perez et al. (2013) [75] 158 46 * 58.2 NR NA 67.1 IIEF-5
Romero-Velez et al. (2014) [94] 109 39.9 ± 8.8 * 70.6 NR NR 65 IIEF-15
Hart et al. (2015) ¶ [101] 619 47.3 ± 8.9 * 100 NR NR 24.7 IIEF-MSM
Pinzone et al. (2015) [96] 109 47 (40–52) § 54 20.2 NR 65 IIEF-15
Fumaz et al. (2017) [97] 501 42 (35–48) § 75.8 NR NA 58.4 IIEF-5
Aghahowa et al. (2017) [98] 217 37.9 ± 9.9 * 63.6 9.5 NR 82.3 IIEF-15
Dijkstra et al. (2018) ¶ [73] 399 53.6 (48.6–60.0) § 100 2 7 13 IIEF-15 ‡‡
Veras Gomes et al. (2019) [99] 134 44.7 ± 11.0 * 40 NR NR 22 IIEF-15
Bernal et al. (2019) [100] 139 45.22 ± 10.47 * 55.6 3.7 NA 61.2 IIEF-5

* Mean ± standard deviation § Median ± interquartile range All studies were cross-sectional, non-controlled except for ¶ prospective controlled study. ** Web-based self-filled International Index of Erectile Function-5 (IIEF-5). ‡‡ In these studies, the authors used a not-validated modified version of IIEF-15. Abbreviations: IIEF, International Index of Erectile Function; ED, erectile dysfunction; HAART, highly active antiretroviral therapy; IV, intravenous; MSM, men who have sex with men; NA, not applicable; NR, not reported; SD, sexual desire.